Alex Smith to Antineoplastic Agents
This is a "connection" page, showing publications Alex Smith has written about Antineoplastic Agents.
Connection Strength
0.147
-
Targeting eIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer. J Clin Invest. 2023 12 15; 133(24).
Score: 0.116
-
CREB-binding protein/P300 bromodomain inhibition reduces neutrophil accumulation and activates antitumor immunity in triple-negative breast cancer. JCI Insight. 2024 Sep 17; 9(20).
Score: 0.031